Study #2016-0244
Feasibility of Single Session In-Room Yttrium-90 Radioembolization Diagnostic Angiography and Treatment
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This clinical trial studies the side effects and best way to perform yttrium Y-90 radioembolization in treating patients with liver cancer that has spread to other places in the body (metastatic). Yttrium Y-90 radioembolization is a therapy that injects radioactive microspheres directly into an artery that feeds liver tumors to cut off their blood supply. Performing yttrium Y-90 radioembolization in a single session may make treatment faster, minimize patient travel, and decrease the overall cost of the procedure.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Metastatic Liver Carcinoma;Stage IV Liver Cancer;Stage IVA Liver Cancer;Stage IVB Liver Cancer
Study phase:
Phase I
Physician name:
Armeen Mahvash
Department:
Interventional Radiology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.